Financials Warby Parker Inc.

Equities

WRBY

US93403J1060

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-29 pm EDT 5-day change 1st Jan Change
12.47 USD -3.48% Intraday chart for Warby Parker Inc. +0.73% -11.56%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,270 1,560 1,659 1,482 - -
Enterprise Value (EV) 1 5,013 1,351 1,659 1,230 1,191 1,094
P/E ratio -21.1 x -14.1 x -26.1 x -94.7 x 125 x 77.9 x
Yield - - - - - -
Capitalization / Revenue 9.74 x 2.61 x 2.48 x 1.96 x 1.74 x 1.54 x
EV / Revenue 9.27 x 2.26 x 2.48 x 1.63 x 1.4 x 1.14 x
EV / EBITDA 202 x 49.7 x 31.7 x 18.4 x 13.7 x 9.75 x
EV / FCF -62.3 x -27.1 x - 159 x -213 x -
FCF Yield -1.61% -3.69% - 0.63% -0.47% -
Price to Book 11.6 x 5.43 x - 4.44 x 4.04 x 3.26 x
Nbr of stocks (in thousands) 113,183 115,624 117,640 118,837 - -
Reference price 2 46.56 13.49 14.10 12.47 12.47 12.47
Announcement Date 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 393.7 540.8 598.1 669.8 755.2 850.9 962.2
EBITDA 1 - 24.86 27.2 52.35 66.92 86.98 112.1
EBIT 1 - -33.12 -6.556 13.8 22.68 37.37 57.31
Operating Margin - -6.12% -1.1% 2.06% 3% 4.39% 5.96%
Earnings before Tax (EBT) 1 - -144 -109.9 -62.76 -4.443 19.57 28.99
Net income 1 - -144.3 -110.4 -63.2 -11 10.03 20.97
Net margin - -26.68% -18.46% -9.44% -1.46% 1.18% 2.18%
EPS 2 -1.050 -2.210 -0.9600 -0.5400 -0.1317 0.1000 0.1600
Free Cash Flow 1 - -80.51 -49.81 - 7.748 -5.6 -
FCF margin - -14.89% -8.33% - 1.03% -0.66% -
FCF Conversion (EBITDA) - - - - 11.58% - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share 2 - - - - - - -
Announcement Date 6/21/21 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 137.4 132.9 153.2 149.6 148.8 146.5 172 166.1 169.8 161.9 196.4 187 189.1 182.5 215.8
EBITDA 1 11.19 -6.399 0.774 5.936 11.93 8.568 17.74 14.18 11.03 9.408 19.43 16.66 17.69 12.65 25.06
EBIT 1 -91.98 -12.95 -6.363 -1.944 2.487 -0.64 7.436 4.891 1.271 -0.962 8.944 5.729 6.967 1.308 13.42
Operating Margin -66.96% -9.74% -4.15% -1.3% 1.67% -0.44% 4.32% 2.94% 0.75% -0.59% 4.55% 3.06% 3.68% 0.72% 6.22%
Earnings before Tax (EBT) 1 -92.12 -45.79 -33.59 -32.12 -23.86 -20.33 -10.55 -15.95 -17.11 -19.15 1.154 0.7053 2.735 -3.261 -
Net income 1 -91.07 -45.9 -34.13 -32.17 -23.84 -20.25 -10.81 -15.92 -17.41 -19.05 -3.821 -3.391 0.6302 -3.518 -
Net margin -66.3% -34.54% -22.28% -21.5% -16.03% -13.82% -6.29% -9.59% -10.25% -11.77% -1.95% -1.81% 0.33% -1.93% -
EPS 2 -0.8175 -0.4100 -0.3000 -0.2800 -0.2100 -0.1800 -0.0900 -0.1400 -0.1500 -0.1600 -0.0480 -0.0520 -0.0100 -0.0400 0.0100
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/12/21 3/17/22 5/16/22 8/11/22 11/10/22 2/28/23 5/9/23 8/9/23 11/8/23 2/28/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 256 209 - 252 291 388
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -80.5 -49.8 - 7.75 -5.6 -
ROE (net income / shareholders' equity) - -328% -1.29% - 6.33% 7.11% 8.1%
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - 4.010 2.490 - 2.810 3.090 3.830
Cash Flow per Share 2 - - 0.0900 - -0.5000 -0.5500 -
Capex 1 - 48.5 60.2 - 59.9 58 63.1
Capex / Sales - 8.97% 10.06% - 7.94% 6.81% 6.56%
Announcement Date 6/21/21 3/17/22 2/28/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
12.47 USD
Average target price
15.17 USD
Spread / Average Target
+21.63%
Consensus
  1. Stock Market
  2. Equities
  3. WRBY Stock
  4. Financials Warby Parker Inc.